Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
Limited Edition Golden Llama is here! Check out how you can get one. 
Limited Edition Golden Llama is here! Check out how you can get one.
Happy Holiday! Limited Keychain here with your next orderHappy Holiday! Limited Keychain here with your next order
Time Limited Offer: Welcome Gift for New Customers ! Shipping Price Reduction for EU Regions
A-Z
> Characterization and Functional Analysis Using Flow Cytometry
Harnessing the power of ACROBiosystems' advanced flow cytometry platform, we deliver precise drug characterization and activity analysis, driving unparalleled excellence in drug quality control and clinical evaluation.
Drug characterization, activity, and safety evaluations are fundamental to successful drug development. In CAR-T cell therapy, for instance, CAR-positive rate analysis determines the proportion of cells effectively targeting tumors, while insufficient cell purity can compromise therapeutic efficacy. Researchers leverage this data to optimize manufacturing processes and ensure product integrity. Furthermore, the specific requirements for T cell subpopulations at different disease stages can be precisely assessed through the analysis of cell markers, morphology, and metabolic profiles. Flow cytometry plays an indispensable role in this process, delivering critical insights that underpin the efficacy and success of cell therapies.
Flow cytometry is a highly versatile and powerful technology, offering significant potential for advanced biomarker screening and multi-parameter cellular profiling. It plays a critical role in drug quality control and clinical evaluation. To expedite the drug development process, ACROBiosystems offers cutting-edge flow cytometry-based solutions, including fluorescent-labeled proteins and antibodies, as well as multiplex bead assays. These solutions are designed to meet diverse research needs, such as CAR-positive cell quantification, cell phenotyping, and multi-protein quantification, supporting the advancement of therapeutic innovations.
We offer an innovative flow cytometry platform that delivers comprehensive products and solutions to clients worldwide. By seamlessly integrating with diverse application scenarios, our platform is strategically designed to support a broad spectrum of needs, ranging from early-stage biopharmaceutical research to CMC processes and clinical testing. With a focus on driving innovation, we provide the expertise and resources to help you navigate complex scientific challenges and accelerate progress across critical stages of development. Contact us to explore how we can collaborate to advance your most impactful programs.
Multi-platform, multi-scenario product application development, spanning early-stage biopharmaceutical research, CMC, and clinical application.
End-to-end product translation compliant with ISO 13485 and GMP standards.
Flexible semi-customized services and professional FAS customer support.
This web search service is supported by Google Inc.
